Cell culture platforms to study ABCA-3 deficiency in vitro

Research output: ThesisDoctoral Thesis

235 Downloads (Pure)

Abstract

Dysfunction of type II alveolar cells due to deficiency in the lipid transporter protein, ATP-binding cassette subfamily A member3 (ABCA-3), can cause lung disease in children. The development of therapeutics to treat ABCA-3 deficiency has been hindered by the lack of appropriate cell culture models. This thesis investigates two alternative cells culture platforms, primary nasal epithelial cells and induced pluripotent stem cell-derived alveolospheres, to determine their biological relevance as type II alveolar cell surrogates. While neither of the cell culture platforms investigated perfectly recapitulate type II alveolar cell phenotype, further optimisation may generate more usable platforms in future.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Supervisors/Advisors
  • Schultz, Andre, Supervisor
  • Kicic, Anthony, Supervisor
  • Stick, Stephen, Supervisor
  • Wilton, Steve, Supervisor
  • Fletcher, Susan, Supervisor
  • Laing, Ingrid, Supervisor
Thesis sponsors
Award date23 May 2021
DOIs
Publication statusUnpublished - 2021

Fingerprint

Dive into the research topics of 'Cell culture platforms to study ABCA-3 deficiency in vitro'. Together they form a unique fingerprint.

Cite this